BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10500066)

  • 1. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
    Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
    Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.
    Kishimoto Y; Takata N; Jinnai T; Morisawa T; Shiota G; Kawasaki H; Hasegawa J
    Gut; 2000 Dec; 47(6):812-9. PubMed ID: 11076880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T
    J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.
    Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H
    Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
    Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.
    Yoshimi N; Shimizu M; Matsunaga K; Yamada Y; Fujii K; Hara A; Mori H
    Jpn J Cancer Res; 1999 Apr; 90(4):406-12. PubMed ID: 10363578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci.
    Kim KP; Whitehead C; Piazza G; Wargovich MJ
    Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.
    Piazza GA; Alberts DS; Hixson LJ; Paranka NS; Li H; Finn T; Bogert C; Guillen JM; Brendel K; Gross PH; Sperl G; Ritchie J; Burt RW; Ellsworth L; Ahnen DJ; Pamukcu R
    Cancer Res; 1997 Jul; 57(14):2909-15. PubMed ID: 9230200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
    Ohishi T; Kishimoto Y; Miura N; Shiota G; Kohri T; Hara Y; Hasegawa J; Isemura M
    Cancer Lett; 2002 Mar; 177(1):49-56. PubMed ID: 11809530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
    Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
    Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention for colorectal tumorigenesis associated with chronic colitis in mice via apoptosis.
    Orii S; Yamaguchi T; Anzai H; Saito S; Chiba T; Suzuki K
    J Exp Clin Cancer Res; 2003 Mar; 22(1):41-6. PubMed ID: 12725321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.